IDEX IEX Health & Science Technologies — Intangible Amortization
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by IDEX in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: IDEX’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEX's health & science technologies — intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is IDEX's health & science technologies — intangible amortization?
- IDEX (IEX) reported health & science technologies — intangible amortization of $27.1M in Q1 2026.
- How has IDEX's health & science technologies — intangible amortization changed year-over-year?
- IDEX's health & science technologies — intangible amortization increased by 10.2% year-over-year, from $24.6M to $27.1M.
- What is the long-term trend for IDEX's health & science technologies — intangible amortization?
- Over 3 years (2022 to 2025), IDEX's health & science technologies — intangible amortization has grown at a 35.6% compound annual growth rate (CAGR), from $41.6M to $103.7M.
- What does health & science technologies — intangible amortization mean?
- The periodic expense recognized for the reduction in value of intangible assets, such as patents, trademarks, and customer relationships, acquired by the Health and Science Technologies segment. This reflects the consumption of economic benefits from non-physical assets over time.